Human Gene EPHA4 (ENST00000281821.7) from GENCODE V44
  Description: Homo sapiens EPH receptor A4 (EPHA4), transcript variant 2, mRNA. (from RefSeq NM_004438)
RefSeq Summary (NM_004438): This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015].
Gencode Transcript: ENST00000281821.7
Gencode Gene: ENSG00000116106.12
Transcript (Including UTRs)
   Position: hg38 chr2:221,418,027-221,572,304 Size: 154,278 Total Exon Count: 18 Strand: -
Coding Region
   Position: hg38 chr2:221,426,028-221,572,248 Size: 146,221 Coding Exon Count: 17 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr2:221,418,027-221,572,304)mRNA (may differ from genome)Protein (986 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMalacardsMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: EPHA4_HUMAN
DESCRIPTION: RecName: Full=Ephrin type-A receptor 4; EC=2.7.10.1; AltName: Full=EPH-like kinase 8; Short=EK8; Short=hEK8; AltName: Full=Tyrosine-protein kinase TYRO1; AltName: Full=Tyrosine-protein kinase receptor SEK; Flags: Precursor;
FUNCTION: Receptor tyrosine kinase which binds membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous, it has the unique property among Eph receptors to bind and to be physiologically activated by both GPI-anchored ephrin-A and transmembrane ephrin-B ligands including EFNA1 and EFNB3. Upon activation by ephrin ligands, modulates cell morphology and integrin-dependent cell adhesion through regulation of the Rac, Rap and Rho GTPases activity. Plays an important role in the development of the nervous system controlling different steps of axonal guidance including the establishment of the corticospinal projections. May also control the segregation of motor and sensory axons during neuromuscular circuit development. Beside its role in axonal guidance plays a role in synaptic plasticity. Activated by EFNA1 phosphorylates CDK5 at 'Tyr-15' which in turn phosphorylates NGEF regulating RHOA and dendritic spine morphogenesis. In the nervous system, plays also a role in repair after injury preventing axonal regeneration and in angiogenesis playing a role in central nervous system vascular formation. Additionally, its promiscuity makes it available to participate in a variety of cell-cell signaling regulating for instance the development of the thymic epithelium.
CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
SUBUNIT: Heterotetramer upon binding of the ligand. The heterotetramer is composed of an ephrin dimer and a receptor dimer. Oligomerization is probably required to induce biological responses. Interacts (phosphorylated at position Tyr-602) with FYN. Interacts with CDK5, CDK5R1 and NGEF; upon activation by EFNA1 induces NGEF phosphorylation by the kinase CDK5. Interacts with CHN1; effector of EPHA4 in axon guidance linking EPHA4 activation to RAC1 regulation (By similarity). Interacts (via PDZ motif) with SIPA1L1 (via PDZ domain); controls neuronal morphology through regulation of the RAP1 (RAP1A or RAP1B) and RAP2 (RAP2A, RAP2B or RAP2C) GTPases.
SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein (By similarity). Cell projection, axon (By similarity). Cell projection, dendrite (By similarity). Cell junction, synapse, postsynaptic cell membrane, postsynaptic density (By similarity). Early endosome (By similarity). Note=Clustered upon activation and targeted to early endosome (By similarity).
TISSUE SPECIFICITY: Ubiquitous.
DOMAIN: The protein kinase domain mediates interaction with NGEF (By similarity).
SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily.
SIMILARITY: Contains 1 Eph LBD (Eph ligand-binding) domain.
SIMILARITY: Contains 2 fibronectin type-III domains.
SIMILARITY: Contains 1 protein kinase domain.
SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: EPHA4
Diseases sorted by gene-association score: lung mucoepidermoid carcinoma (7), ureterocele (6), paralytic squint (6), amyotrophic lateral sclerosis 1* (5)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 15.17 RPKM in Brain - Frontal Cortex (BA9)
Total median expression: 202.29 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -14.3056-0.255 Picture PostScript Text
3' UTR -889.303345-0.266 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001090 - Ephrin_rcpt_lig-bd_dom
IPR003961 - Fibronectin_type3
IPR008979 - Galactose-bd-like
IPR013783 - Ig-like_fold
IPR011009 - Kinase-like_dom
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR001660 - SAM
IPR013761 - SAM/pointed
IPR011510 - SAM_2
IPR001245 - Ser-Thr/Tyr_kinase_cat_dom
IPR008266 - Tyr_kinase_AS
IPR020635 - Tyr_kinase_cat_dom
IPR016257 - Tyr_kinase_ephrin_rcpt
IPR001426 - Tyr_kinase_rcpt_V_CS

Pfam Domains:
PF01404 - Ephrin receptor ligand binding domain
PF00041 - Fibronectin type III domain
PF07714 - Protein tyrosine kinase
PF07647 - SAM domain (Sterile alpha motif)

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2WO1 - X-ray MuPIT 2WO2 - X-ray MuPIT 2WO3 - X-ray MuPIT 3CKH - X-ray MuPIT 3GXU - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P54764
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGD    
Protein SequenceProtein Sequence    
AlignmentAlignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0004672 protein kinase activity
GO:0004713 protein tyrosine kinase activity
GO:0004714 transmembrane receptor protein tyrosine kinase activity
GO:0005003 ephrin receptor activity
GO:0005004 GPI-linked ephrin receptor activity
GO:0005005 transmembrane-ephrin receptor activity
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0042731 PH domain binding
GO:0042802 identical protein binding
GO:0046875 ephrin receptor binding
GO:0097161 DH domain binding
GO:1990782 protein tyrosine kinase binding

Biological Process:
GO:0006468 protein phosphorylation
GO:0007155 cell adhesion
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0007275 multicellular organism development
GO:0007399 nervous system development
GO:0007411 axon guidance
GO:0007628 adult walking behavior
GO:0008045 motor neuron axon guidance
GO:0008347 glial cell migration
GO:0010977 negative regulation of neuron projection development
GO:0016310 phosphorylation
GO:0018108 peptidyl-tyrosine phosphorylation
GO:0021957 corticospinal tract morphogenesis
GO:0043087 regulation of GTPase activity
GO:0043507 positive regulation of JUN kinase activity
GO:0046777 protein autophosphorylation
GO:0048013 ephrin receptor signaling pathway
GO:0048681 negative regulation of axon regeneration
GO:0048710 regulation of astrocyte differentiation
GO:0050770 regulation of axonogenesis
GO:0050775 positive regulation of dendrite morphogenesis
GO:0050821 protein stabilization
GO:0061001 regulation of dendritic spine morphogenesis
GO:0061098 positive regulation of protein tyrosine kinase activity
GO:0072178 nephric duct morphogenesis
GO:0097155 fasciculation of sensory neuron axon
GO:0097156 fasciculation of motor neuron axon
GO:0097485 neuron projection guidance
GO:1900272 negative regulation of long-term synaptic potentiation
GO:1902004 positive regulation of beta-amyloid formation
GO:1902961 positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process
GO:1903051 negative regulation of proteolysis involved in cellular protein catabolic process
GO:1904646 cellular response to beta-amyloid
GO:1905244 regulation of modification of synaptic structure
GO:2001108 positive regulation of Rho guanyl-nucleotide exchange factor activity

Cellular Component:
GO:0005737 cytoplasm
GO:0005741 mitochondrial outer membrane
GO:0005768 endosome
GO:0005769 early endosome
GO:0005783 endoplasmic reticulum
GO:0005794 Golgi apparatus
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0009986 cell surface
GO:0014069 postsynaptic density
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030054 cell junction
GO:0030175 filopodium
GO:0030424 axon
GO:0030425 dendrite
GO:0031594 neuromuscular junction
GO:0031901 early endosome membrane
GO:0042995 cell projection
GO:0043197 dendritic spine
GO:0043198 dendritic shaft
GO:0043204 perikaryon
GO:0043679 axon terminus
GO:0044295 axonal growth cone
GO:0044297 cell body
GO:0045202 synapse
GO:0045211 postsynaptic membrane


-  Descriptions from all associated GenBank mRNAs
  LF205260 - JP 2014500723-A/12763: Polycomb-Associated Non-Coding RNAs.
MA440837 - JP 2018138019-A/12763: Polycomb-Associated Non-Coding RNAs.
JA482307 - Sequence 290 from Patent WO2011072091.
JE980599 - Sequence 290 from Patent EP2862929.
AK225181 - Homo sapiens mRNA for ephrin receptor EphA4 variant, clone: CBR06796.
LP882420 - Sequence 15 from Patent WO2017180581.
L36645 - Homo sapiens receptor protein-tyrosine kinase (HEK8) mRNA, complete cds.
BC026327 - Homo sapiens EPH receptor A4, mRNA (cDNA clone MGC:26318 IMAGE:4814429), complete cds.
AK300772 - Homo sapiens cDNA FLJ53205 complete cds, highly similar to Ephrin type-A receptor 4 precursor (EC 2.7.10.1).
AK290306 - Homo sapiens cDNA FLJ78431 complete cds, highly similar to Homo sapiens EPH receptor A4 (EPHA4), mRNA.
BC105000 - Homo sapiens EPH receptor A4, mRNA (cDNA clone MGC:132660 IMAGE:8144003), complete cds.
BC105002 - Homo sapiens EPH receptor A4, mRNA (cDNA clone MGC:132662 IMAGE:8144005), complete cds.
AK312380 - Homo sapiens cDNA, FLJ92707, highly similar to Homo sapiens EphA4 (EPHA4), mRNA.
BC036860 - Homo sapiens mRNA similar to EphA4 (cDNA clone IMAGE:5165840).
LY623325 - KR 1020180134347-A/15: DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER.
MB416868 - JP 2019518426-A/8: DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER.
BC016981 - Homo sapiens EPH receptor A4, mRNA (cDNA clone IMAGE:4183576).
JD566737 - Sequence 547761 from Patent EP1572962.
LF318672 - JP 2014500723-A/126175: Polycomb-Associated Non-Coding RNAs.
MA554249 - JP 2018138019-A/126175: Polycomb-Associated Non-Coding RNAs.
JD145514 - Sequence 126538 from Patent EP1572962.
JD196922 - Sequence 177946 from Patent EP1572962.
JD563444 - Sequence 544468 from Patent EP1572962.
JD080917 - Sequence 61941 from Patent EP1572962.
JD326441 - Sequence 307465 from Patent EP1572962.
LF318673 - JP 2014500723-A/126176: Polycomb-Associated Non-Coding RNAs.
MA554250 - JP 2018138019-A/126176: Polycomb-Associated Non-Coding RNAs.
JD438322 - Sequence 419346 from Patent EP1572962.
JD041933 - Sequence 22957 from Patent EP1572962.
JD131389 - Sequence 112413 from Patent EP1572962.
JD432833 - Sequence 413857 from Patent EP1572962.
JD233354 - Sequence 214378 from Patent EP1572962.
JD244234 - Sequence 225258 from Patent EP1572962.
LF318674 - JP 2014500723-A/126177: Polycomb-Associated Non-Coding RNAs.
MA554251 - JP 2018138019-A/126177: Polycomb-Associated Non-Coding RNAs.
JD565385 - Sequence 546409 from Patent EP1572962.
KJ904461 - Synthetic construct Homo sapiens clone ccsbBroadEn_13855 EPHA4 gene, encodes complete protein.
LF318675 - JP 2014500723-A/126178: Polycomb-Associated Non-Coding RNAs.
MA554252 - JP 2018138019-A/126178: Polycomb-Associated Non-Coding RNAs.
AF075040 - Homo sapiens full length insert cDNA YN63B03.
LF318676 - JP 2014500723-A/126179: Polycomb-Associated Non-Coding RNAs.
MA554253 - JP 2018138019-A/126179: Polycomb-Associated Non-Coding RNAs.
LF318677 - JP 2014500723-A/126180: Polycomb-Associated Non-Coding RNAs.
MA554254 - JP 2018138019-A/126180: Polycomb-Associated Non-Coding RNAs.
LF318680 - JP 2014500723-A/126183: Polycomb-Associated Non-Coding RNAs.
MA554257 - JP 2018138019-A/126183: Polycomb-Associated Non-Coding RNAs.
LF318681 - JP 2014500723-A/126184: Polycomb-Associated Non-Coding RNAs.
MA554258 - JP 2018138019-A/126184: Polycomb-Associated Non-Coding RNAs.
LF318683 - JP 2014500723-A/126186: Polycomb-Associated Non-Coding RNAs.
MA554260 - JP 2018138019-A/126186: Polycomb-Associated Non-Coding RNAs.
E09452 - cDNA encoding human sec receptor-type tyrosine kinase.
LF318693 - JP 2014500723-A/126196: Polycomb-Associated Non-Coding RNAs.
MA554270 - JP 2018138019-A/126196: Polycomb-Associated Non-Coding RNAs.
LF318696 - JP 2014500723-A/126199: Polycomb-Associated Non-Coding RNAs.
MA554273 - JP 2018138019-A/126199: Polycomb-Associated Non-Coding RNAs.
LF318701 - JP 2014500723-A/126204: Polycomb-Associated Non-Coding RNAs.
MA554278 - JP 2018138019-A/126204: Polycomb-Associated Non-Coding RNAs.
LF318703 - JP 2014500723-A/126206: Polycomb-Associated Non-Coding RNAs.
MA554280 - JP 2018138019-A/126206: Polycomb-Associated Non-Coding RNAs.
LF318720 - JP 2014500723-A/126223: Polycomb-Associated Non-Coding RNAs.
MA554297 - JP 2018138019-A/126223: Polycomb-Associated Non-Coding RNAs.
LF318721 - JP 2014500723-A/126224: Polycomb-Associated Non-Coding RNAs.
MA554298 - JP 2018138019-A/126224: Polycomb-Associated Non-Coding RNAs.
LF318761 - JP 2014500723-A/126264: Polycomb-Associated Non-Coding RNAs.
MA554338 - JP 2018138019-A/126264: Polycomb-Associated Non-Coding RNAs.
LF318762 - JP 2014500723-A/126265: Polycomb-Associated Non-Coding RNAs.
MA554339 - JP 2018138019-A/126265: Polycomb-Associated Non-Coding RNAs.
LF318763 - JP 2014500723-A/126266: Polycomb-Associated Non-Coding RNAs.
MA554340 - JP 2018138019-A/126266: Polycomb-Associated Non-Coding RNAs.
LF318764 - JP 2014500723-A/126267: Polycomb-Associated Non-Coding RNAs.
MA554341 - JP 2018138019-A/126267: Polycomb-Associated Non-Coding RNAs.
LF318772 - JP 2014500723-A/126275: Polycomb-Associated Non-Coding RNAs.
MA554349 - JP 2018138019-A/126275: Polycomb-Associated Non-Coding RNAs.
LF211747 - JP 2014500723-A/19250: Polycomb-Associated Non-Coding RNAs.
MA447324 - JP 2018138019-A/19250: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04360 - Axon guidance

BioCarta from NCI Cancer Genome Anatomy Project
h_ephA4Pathway - Eph Kinases and ephrins support platelet aggregation

Reactome (by CSHL, EBI, and GO)

Protein P54764 (Reactome details) participates in the following event(s):

R-HSA-3928646 EPHAs bind EFNAs
R-HSA-3928597 EPH:EFN dimers tetramerise
R-HSA-2682334 EPH-Ephrin signaling
R-HSA-3928665 EPH-ephrin mediated repulsion of cells
R-HSA-422475 Axon guidance
R-HSA-1266738 Developmental Biology

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000281821.1, ENST00000281821.2, ENST00000281821.3, ENST00000281821.4, ENST00000281821.5, ENST00000281821.6, EPHA4_HUMAN, HEK8, NM_004438, P54764, Q2M380, SEK, TYRO1, uc002vmq.1, uc002vmq.2, uc002vmq.3, uc002vmq.4, uc002vmq.5
UCSC ID: ENST00000281821.7
RefSeq Accession: NM_004438
Protein: P54764 (aka EPHA4_HUMAN)
CCDS: CCDS2447.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.